Compound Summary
valproic acid
Compound Information
VALPROIC ACID
Compound Name: | VALPROIC ACID |
Compound CID: | 3121 |
Synonyms: | VALPROIC ACID 2-Propylpentanoic acid 99-66-1 2-Propylvaleric acid Dipropylacetic acid More... |
Iupac Name: | 2-propylpentanoic acid |
InChI: | InChI=1S/C8H16O2/c1-3-5-7(6-4-2)8(9)10/h7H,3-6H2,1-2H3,(H,9,10) |
InChIKey: | NIJJYAXOARWZEE-UHFFFAOYSA-N |
Canonical Smiles: | CCCC(CCC)C(=O)O |
Isomeric Smiles: | CCCC(CCC)C(=O)O |
Molecular Weight: | 144.21 |
Molecular Formula: | C8H16O2 |
Compound Structure
2D Structure:
3D Structure:
Computed Properties
VALPROIC ACID
Molecular Weight: | 144.21 |
Molecular Formula: | C8H16O2 |
Hydrogen Bond Donor Count: | 1 |
Hydrogen Bond Acceptor Count: | 2 |
Rotatable Bond Count: | 5 |
Heavy Atom Count: | 10 |
Complexity: | 93.4 |
Synonyms
VALPROIC ACID
| VALPROIC ACID | VALPROIC ACID |
|---|---|
VALPROIC ACID |
2-Propylpentanoic acid |
99-66-1 |
2-Propylvaleric acid |
Dipropylacetic acid |
Depakine |
Depakene |
Ergenyl |
Di-n-propylacetic acid |
Valproate |
Mylproin |
Pentanoic acid, 2-propyl- |
4-Heptanecarboxylic acid |
n-Dipropylacetic acid |
Propylvaleric acid |
Myproic Acid |
n-DPA |
Dipropylacetate |
Convulex |
Depakin |
Di-n-propylessigsaure |
Avugane |
Baceca |
Stavzor |
Acido valproico |
Kyselina 2-propylvalerova |
Acide valproique |
2-n-Propyl-n-valeric acid |
Acidum valproicum |
Acetic acid, dipropyl- |
2,2-di-n-propylacetic acid |
Valproinsaeure |
Savicol |
Depakine chrono |
Depakin chrono |
Abbott 44090 |
Acide valproique INN-French |
Acido valproico INN-Spanish |
Acidum valproicum INN-Latin |
2-PROPYL-PENTANOIC ACID |
Di-n-propylessigsaure German |
Valeric acid, 2-propyl- |
divalproex |
Epilim |
Kyselina 2-propylvalerova Czech |
Di-n-propylessigsaeure |
VPA |
VPA;2-Propylpentanoic Acid |
UNII-614OI1Z5WI |
NSC 93819 |
Delepsine |
Sprinkle |
Valcote |
Valparin |
Epilex |
PEAC |
Depakene (TN) |
MFCD00002672 |
Vupral |
CHEMBL109 |
(n-C3H7)2CHCOOH |
614OI1Z5WI |
CHEBI:39867 |
Valerin |
NSC-93819 |
NCGC00091149-01 |
Deproic |
Alti-Valproic |
Novo-Valproic |
Penta-Valproic |
Dom-Valproic |
Med Valproic |
Nu-Valproic |
DSSTox_CID_3733 |
DSSTox_RID_77171 |
DSSTox_GSID_23733 |
Valproic acid USP |
PMS-Valproic Acid |
Valproic acid (USP) |
CAS-99-66-1 |
Depakote (TM) |
SMR000499581 |
HSDB 3582 |
2 PP (base) |
EINECS 202-777-3 |
BRN 1750447 |
valproic-acid |
Novo-divalproex |
Sandoz valproic |
Dom-valproate |
Gen-divalproex |
Apo-valproic |
A-44090 |
AI3-10500 |
APO-divalproex |
DOM-divalproex |
Epival er |
PHL-valproate |
PMS-valproate |
PMS-Divalproex |
Erganyl; Stavzor |
Dom-valproic acid |
Apo-valproic syrup |
PHL-valproic acid |
Epiject I.V. |
2-propyl-Pentanoate |
Epical (TM) |
Epilim (Salt/Mix) |
Valproic acid USAN:USP:INN:BAN |
Depacon (Salt/Mix) |
Convulex (Salt/Mix) |
Eurekene (Salt/Mix) |
G2M-777 |
Valparin (Salt/Mix) |
Valproic acid solution |
Novo-Valproic - ECC |
Spectrum_000521 |
Divalproex (Salt/Mix) |
Dom-valproic acid syrup |
Ratio-Valproic - ECC |
Valdisoval (Salt/Mix) |
ACMC-209sdq |
2 -propylpentanoic acid |
di-n-propyl acetic acid |
S(-)-4-En-valproate |
Spectrum2_000946 |
Spectrum3_001733 |
Spectrum4_000376 |
DOM-valproic acid E.C. |
PHL-valproic acid E.C. |
PMS-valproic acid E.C. |
Novo-valproic soft gel cap |
EC 202-777-3 |
SCHEMBL2275 |
S-2-n-Propyl-4-pentenoate |
(S)-2-propyl-4-pentanoate |
KBioGR_000871 |
KBioGR_002277 |
KBioSS_001001 |
KBioSS_002278 |
MLS001076682 |
MLS001335927 |
MLS001335928 |
MLS002415770 |
BIDD:GT0858 |
DivK1c_000273 |
SPBio_000912 |
GTPL7009 |
DTXSID6023733 |
WLN: QVY3 & 3 |
KBio1_000273 |
KBio2_001001 |
KBio2_002277 |
KBio2_003569 |
KBio2_004845 |
KBio2_006137 |
KBio2_007413 |
KBio3_002626 |
KBio3_002757 |
NIJJYAXOARWZEE-UHFFFAOYSA- |
Valproic acid USAN:BAN:INN |
NINDS_000273 |
HMS2089J06 |
HMS2231E06 |
HMS3259C18 |
HMS3370C21 |
HMS3715B15 |
HMS3885G14 |
ACT05281 |
ALBB-032973 |
BCP33204 |
NSC93819 |
ZINC3008621 |
Tox21_111091 |
Tox21_201963 |
Tox21_300603 |
BDBM50003616 |
LMFA01020291 |
s3944 |
SBB065764 |
STL445581 |
AKOS009156895 |
Tox21_111091_1 |
Valproic Acid 1.0 mg/ml in Methanol |
CCG-221127 |
CS-1765 |
DB00313 |
MCULE-7136317196 |
NC00584 |
SDCCGSBI-0050864.P004 |
NCGC00091149-02 |
NCGC00091149-03 |
NCGC00091149-04 |
NCGC00091149-05 |
NCGC00091149-06 |
NCGC00091149-08 |
NCGC00091149-09 |
NCGC00091149-26 |
NCGC00162288-07 |
NCGC00254365-01 |
NCGC00259512-01 |
AS-11354 |
HY-10585 |
SBI-0050864.P003 |
AB0009719 |
791-EP2306789A1 |
FT-0609289 |
FT-0675769 |
P0823 |
6400-EP1441224A2 |
6400-EP2272537A2 |
6400-EP2272827A1 |
6400-EP2275420A1 |
6400-EP2280008A2 |
6400-EP2298764A1 |
6400-EP2298765A1 |
6400-EP2308867A2 |
6400-EP2308870A2 |
6400-EP2311494A1 |
6400-EP2311840A1 |
6400-EP2314585A1 |
6400-EP2374790A1 |
A19450 |
C07185 |
D00399 |
AB00698315-06 |
Q240642 |
Q-200321 |
Sodium valproate; 2-Propylpentanoic acid sodium salt |
SR-01000075242-7 |
F2191-0115 |
Z1511532065 |
Valproic acid, European Pharmacopoeia (EP) Reference Standard |
Valproic acid, United States Pharmacopeia (USP) Reference Standard |
Valproic acid for system suitability, European Pharmacopoeia (EP) Reference Standard |
Valproic acid solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material |
Valproic acid, Pharmaceutical Secondary Standard; Certified Reference Material |
Experimental Data
VALPROIC ACID
| Species | Dose | Unit | Control(Avg days) | Treatment(Avg days) | Avg/Med Lifespan Change(%) | Control(Max days) | Treatment(Max days) | Max Lifespan Change(%) | Significant | Strain | Gender | PubMed | Avg/Med Lifespan Change tab |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Caenorhabditis elegans | 50.000000000000000 | umol/L | 13.240000000000000 | S | N2 | 30970250 | Active | ||||||
| Caenorhabditis elegans | 50.000000000000000 | umol/L | 4.160000000000000 | S | N2 | 30970250 | Active | ||||||
| Apis mellifera | 0.100000000000000 | mg/mL | 0.000000000000000 | S | 34580381 | Active | |||||||
| Apis mellifera | 10.000000000000000 | mg/mL | 0.000000000000000 | S | 34580381 | Inactive | |||||||
| Apis mellifera | 1.000000000000000 | mg/mL | 0.000000000000000 | S | 34580381 | Inactive | |||||||
| Caenorhabditis elegans | 6.000000000000000 | mM | 16.200000000000000 | 21.900000000000000 | 35.000000000000000 | 23.300000000000000 | 33.100000000000000 | 42.000000000000000 | S | N2 | 18248662 | Active | |
| Caenorhabditis elegans | 3.000000000000000 | mM | 16.200000000000000 | 20.900000000000000 | 29.000000000000000 | 23.300000000000000 | 33.300000000000000 | 43.000000000000000 | S | N2 | 18248662 | Active |
Experimental Data Visualization
VALPROIC ACID
Statistics Data
VALPROIC ACID
| Species | Avg/Med Lifespan Change(%) | Max Lifespan Change(%) | Count Reference | Count Data point |
|---|---|---|---|---|
| Apis mellifera | 0.000000000000000 | 1 | 3 | |
| Caenorhabditis elegans | 35.000000000000000 | 43.000000000000000 | 2 | 4 |
Statistics Data Visualization
VALPROIC ACID
